OR WAIT null SECS
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Pharmaceutical Technology's In the Lab eNewsletter
The quality control from ZeptoMetrix is formulated with purified intact viral particles that have been chemically modified to render them non-infectious and refrigerator stable.
On May 5, 2020, ZeptoMetrix announced its new, ready-to-use NATtrol, a SARS-CoV-2 molecular quality control for laboratory QC and test validation.
According to a company press release, the quality control is formulated with purified intact viral particles that have been chemically modified to render them non-infectious and refrigerator stable, including:
Complementing the release of the positive control is a negative control formulated with human A549 cells:
"Due to the unprecedented COVID-19 pandemic, we were tasked to develop and deploy reliable, user-friendly commercial solutions for ready-to-use, non-infectious SARS-CoV-2 full process molecular quality controls under accelerated timelines,” said Shawn R. Smith, president and CEO of ZeptoMetrix, in the press release. “Today, I am extremely proud to announce that ZeptoMetrix has launched such controls - containing purified intact viral particles of actual SARS-CoV-2 that provide laboratories, hospitals and research facilities with essential external run controls to help ensure the reliability of COVID-19 testing.”
Source: ZeptoMetrix